Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$37.11 - $50.69 $273,649 - $373,788
-7,374 Reduced 62.25%
4,471 $215,000
Q1 2024

May 14, 2024

SELL
$40.65 - $65.76 $158,087 - $255,740
-3,889 Reduced 24.72%
11,845 $568,000
Q4 2023

Feb 13, 2024

SELL
$48.3 - $68.06 $29,559 - $41,652
-612 Reduced 3.74%
15,734 $1.02 Million
Q3 2023

Nov 13, 2023

SELL
$54.2 - $71.67 $3.37 Million - $4.45 Million
-62,154 Reduced 79.18%
16,346 $1.07 Million
Q2 2023

Aug 14, 2023

BUY
$56.23 - $71.17 $4.01 Million - $5.07 Million
71,291 Added 988.92%
78,500 $4.56 Million
Q1 2023

May 15, 2023

SELL
$53.43 - $68.12 $2.01 Million - $2.57 Million
-37,698 Reduced 83.95%
7,209 $445,000
Q4 2022

Feb 14, 2023

BUY
$61.23 - $83.62 $2.75 Million - $3.76 Million
44,907 New
44,907 $2.85 Million
Q4 2021

Feb 01, 2022

SELL
$76.51 - $93.96 $2.79 Million - $3.42 Million
-36,421 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$71.29 - $95.99 $2.6 Million - $3.5 Million
36,421 New
36,421 $2.95 Million
Q1 2021

May 14, 2021

SELL
$77.91 - $125.92 $181,062 - $292,638
-2,324 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$60.0 - $87.29 $139,440 - $202,861
2,324 New
2,324 $203,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.